Fundz
Researching Ancilia Biosciences?

Unlock the full Ancilia Biosciences story — free for 7 days

Start a free Fundz Strategic trial: get everything on Ancilia Biosciences — investors, amounts, verified contacts — plus thousands more funding rounds and a daily AI lead briefing built around your ICP. No credit card.

Everything on Ancilia Biosciences

Investors, amounts, the people behind it — and verified contacts.

Thousands more like it

Search every funding rounds and more — filtered to your market.

AI leads for your ICP

A daily briefing of companies matching exactly who you sell to.

Use your work email — it’s how we set up your trial.

No credit card Full Strategic access for 7 days No commitment

Ancilia Biosciences announced it raised $10.1 Million in an initial filing from an offering of $10.1 Million

PRIVATEApr 06, 2026•3 months ago

Amount Raised

$10.1 Million

New YorkBiotechnology

Company Information

Company

Ancilia Biosciences

Location

3960 BROADWAY, 6TH FLOOR

New York, New York, United States

About

Ancilia develops novel bacterial therapies that target the viral components of the microbiome to address chronic diseases across immunology and oncology indications. Our approach harnesses the natural function of CRISPR to enhance bacterial immunity against viruses and effectively modulate the human microbiome.

Related People

Suggested for you
2 contacts

Choose your plan to reveal verified contacts

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Ancilia Biosciences's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching Ancilia Biosciences? See every signal — funding, hires, M&A, contracts, sentiment.

Request a trialChoose your plan